Plasma protein biomarkers for the prediction of CSF amyloid and tau and [18F]-flutemetamol PET scan result

Plasma protein biomarkers for the prediction of CSF amyloid and tau and [18F]-flutemetamol PET scan result

<strong>Background:</strong> Blood biomarkers may aid in recruitment to clinical trials of Alzheimer’s disease (AD) modifying therapeutics by triaging potential trials participants for amyloid positron emission tomography (PET) or cerebrospinal fluid (CSF) Aβ and tau tests. <strong&g...

Volledige beschrijving

Bibliografische gegevens
Hoofdauteurs:	Westwood, S, Baird, AL, Hye, A, Ashton, NJ, Nevado-Holgado, AJ, Anand, SN, Liu, B, Newby, D, Bazenet, C, Kiddle, SJ, Ward, M, Newton, B, Desai, K, Hehir, C, Zanette, M, Galimberti, D, Parnetti, L, Lleó, A, Baker, S, Narayan, VA, Van Der Flier, WM, Scheltens, P, Teunissen, CE, Visser, PJ, Lovestone, S
Formaat:	Journal article
Gepubliceerd in:	Frontiers Media 2018

Gelijkaardige items

Plasma Protein Biomarkers for the Prediction of CSF Amyloid and Tau and [18F]-Flutemetamol PET Scan Result
door: Sarah Westwood, et al.
Gepubliceerd in: (2018-12-01)

The influence of insulin resistance on CSF and plasma biomarkers of Alzheimer’s pathology
door: Westwood, S, et al.
Gepubliceerd in: (2017)

New CSF biomarkers on the block
door: Charlotte E Teunissen, et al.
Gepubliceerd in: (2016-09-01)

Decision tree supports the interpretation of CSF biomarkers in Alzheimer's disease
door: Rosha Babapour Mofrad, et al.
Gepubliceerd in: (2019-12-01)

Determining the molecular pathways underlying the protective effect of non-steroidal anti-inflammatory drugs for Alzheimer's disease: A bioinformatics approach
door: Nevado-Holgado, A, et al.
Gepubliceerd in: (2016)

CSF proteomic signature predicts progression to Alzheimer's disease dementia
door: Eleonora M. Vromen, et al.
Gepubliceerd in: (2022-01-01)

Blood-based proteomic biomarkers of Alzheimer’s disease pathology
door: Baird, A, et al.
Gepubliceerd in: (2015)

Determining the Molecular Pathways Underlying the Protective Effect of Non-Steroidal Anti-Inflammatory Drugs for Alzheimer's Disease: A Bioinformatics Approach
door: Alejo J Nevado-Holgado, et al.
Gepubliceerd in: (2017-01-01)

CSF Proteomic Alzheimer’s Disease-Predictive Subtypes in Cognitively Intact Amyloid Negative Individuals
door: Betty Marije Tijms, et al.
Gepubliceerd in: (2021-08-01)

Establishing cutoff values for visual amyloid positivity in [18F]flutemetamol PET
door: Yong-Jin Park, et al.
Gepubliceerd in: (2025-01-01)

Amyloid-Targeting PET Tracer [18F]Flutemetamol Accumulates in Atherosclerotic Plaques
door: Sanna Hellberg, et al.
Gepubliceerd in: (2019-03-01)

White paper by the Society for CSF Analysis and Clinical Neurochemistry: Overcoming barriers in biomarker development and clinical translation
door: Teunissen, C, et al.
Gepubliceerd in: (2018)

Clinical outcomes up to 9 years after [18F]flutemetamol amyloid-PET in a symptomatic memory clinic population
door: Lyduine E. Collij, et al.
Gepubliceerd in: (2023-11-01)

Clinical significance of focal ß-amyloid deposition measured by 18F-flutemetamol PET
door: Si Eun Kim, et al.
Gepubliceerd in: (2020-01-01)

Comparing CSF amyloid‐beta biomarker ratios for two automated immunoassays, Elecsys and Lumipulse, with amyloid PET status
door: Eline A. J. Willemse, et al.
Gepubliceerd in: (2021-01-01)

Variability of CSF Alzheimer's disease biomarkers: implications for clinical practice.
door: Stephanie J B Vos, et al.
Gepubliceerd in: (2014-01-01)

Thimet oligopeptidase as a potential CSF biomarker for Alzheimer's disease: A cross‐platform validation study
door: Yanaika S. Hok‐A‐Hin, et al.
Gepubliceerd in: (2023-07-01)

Red blood cell indices and anaemia as causative factors for cognitive function deficits and for Alzheimer's disease
door: Winchester, L, et al.
Gepubliceerd in: (2018)

Centiloid scaling for quantification of brain amyloid with [18F]flutemetamol using multiple processing methods
door: Mark R. Battle, et al.
Gepubliceerd in: (2018-12-01)

White paper by the Society for CSF Analysis and Clinical Neurochemistry: Overcoming barriers in biomarker development and clinical translation
door: Charlotte E. Teunissen, et al.
Gepubliceerd in: (2018-03-01)

Binary classification of ¹⁸F-flutemetamol PET using machine learning: comparison with visual reads and structural MRI.
door: Vandenberghe, R, et al.
Gepubliceerd in: (2013)

Early-phase 18F-FP-CIT and 18F-flutemetamol PET were significantly correlated
door: Young-Sil An, et al.
Gepubliceerd in: (2021-06-01)

Temporal and anatomical distribution of 18F-flutemetamol uptake in canine brain using positron emission tomography
door: Taesik Yun, et al.
Gepubliceerd in: (2020-01-01)

PET and CSF amyloid-β status are differently predicted by patient features: information from discordant cases
door: Juhan Reimand, et al.
Gepubliceerd in: (2019-12-01)

Blood-based biomarker candidates of cerebral amyloid using PiB PET in non-demented elderly
door: Westwood, S, et al.
Gepubliceerd in: (2016)

18F-flutemetamol amyloid imaging in Alzheimer disease and mild cognitive impairment: a phase 2 trial.
door: Vandenberghe, R, et al.
Gepubliceerd in: (2010)

Software compatibility analysis for quantitative measures of [18F]flutemetamol amyloid PET burden in mild cognitive impairment
door: Hugh G. Pemberton, et al.
Gepubliceerd in: (2023-05-01)

Automatic lesion detection and segmentation in 18F-flutemetamol positron emission tomography images using deep learning
door: Chan Ju Ryu
Gepubliceerd in: (2022-12-01)

Optimized dual-time-window protocols for quantitative [18F]flutemetamol and [18F]florbetaben PET studies
door: Fiona Heeman, et al.
Gepubliceerd in: (2019-03-01)

Cross-sectional and longitudinal analyses of outdoor air pollution exposure and cognitive function in UK Biobank
door: Cullen, B, et al.
Gepubliceerd in: (2018)

Commonly prescribed drugs associate with cognitive function: a cross-sectional study in UK Biobank
door: Nevado-Holgado, A, et al.
Gepubliceerd in: (2016)

Identification of a possible proteomic biomarker in Parkinson’s disease: discovery and replication in blood, brain and CSF
door: Winchester, L, et al.
Gepubliceerd in: (2022)

18F-flutemetamol PET/CT imaging in the diagnosis of mild cognitive impairment and Alzheimer's disease：a preliminary study
door: LEI Zhe, et al.
Gepubliceerd in: (2022-07-01)

Infrequent false positive [18F]flutemetamol PET signal is resolved by combined histological assessment of neuritic and diffuse plaques
door: Milos D. Ikonomovic, et al.
Gepubliceerd in: (2018-06-01)

Quantitative Evaluation of 18F-Flutemetamol PET in Patients With Cognitive Impairment and Suspected Alzheimer's Disease: A Multicenter Study
door: Hiroshi Matsuda, et al.
Gepubliceerd in: (2021-01-01)

Blood based proteomic biomarkers of Alzheimer’s disease pathology
door: Alison Louise Baird, et al.
Gepubliceerd in: (2015-11-01)

Plasma biomarkers for amyloid, tau, and cytokines in Down syndrome and sporadic Alzheimer’s disease
door: Carla M. Startin, et al.
Gepubliceerd in: (2019-03-01)

Red blood cell indices and anaemia as causative factors for cognitive function deficits and for Alzheimer’s disease
door: Laura M. Winchester, et al.
Gepubliceerd in: (2018-06-01)

Synaptic protein CSF levels relate to memory scores in individuals without dementia
door: Wesenhagen, KEJ, et al.
Gepubliceerd in: (2025)

Synaptic protein CSF levels relate to memory scores in individuals without dementia
door: Kirsten E. J. Wesenhagen, et al.
Gepubliceerd in: (2025-03-01)